human
noroviru
lead
caus
viral
gastroenter
worldwid
rapid
detect
could
facilit
control
howev
widespread
pointofcar
test
infrequ
done
due
lack
robust
portabl
method
recombinas
polymeras
amplif
rpa
novel
isotherm
method
rapidli
amplifi
detect
nucleic
acid
use
simpl
devic
near
realtim
rtrpa
assay
target
recent
epidem
human
noroviru
strain
new
orlean
develop
evalu
studi
assay
success
detect
purifi
noroviru
rna
multipl
patient
outbreak
isol
limit
detect
log
genom
copi
lgc
compar
report
isotherm
noroviru
amplif
method
assay
also
detect
noroviru
directli
boil
stool
display
better
resist
inhibitor
commonli
use
rtqpcr
assay
assay
specif
amplifi
genom
nonrel
enter
virus
bacteria
assay
detect
noroviru
sampl
littl
min
entir
detect
process
perform
less
min
report
rtrpa
method
show
promis
sensit
pointofcar
detect
epidem
human
noroviru
fastest
human
noroviru
amplif
method
date
human
noroviru
estim
account
fifth
acut
gastroenter
case
worldwid
cost
billion
annual
econom
loss
us
alon
noroviru
especi
troublesom
healthcar
set
outbreak
result
consumpt
resourc
extend
hospit
stay
ward
closur
high
morbid
thu
earli
detect
clinic
infect
import
facilit
rapid
implement
rigor
control
result
reduc
health
care
cost
improv
public
health
detect
human
noroviru
histor
reli
revers
transcriptas
quantit
polymeras
chain
reaction
rtqpcr
howev
method
requir
timeconsum
sampl
prepar
purif
sensit
matrixassoci
inhibitor
rtqpcr
also
reli
bulki
instrument
usual
take
hour
complet
recombinas
polymeras
amplif
rpa
novel
isotherm
pcr
altern
produc
result
minut
less
portabl
instrument
rpa
use
bacteri
recombinas
enzym
anneal
primer
templat
dna
extens
amplif
isotherm
polymeras
basic
rpa
platform
use
concert
revers
transcriptas
fluoresc
probe
system
real
time
detect
viral
pathogen
rna
genom
use
sequenc
repair
enzym
theoret
provid
higher
fidel
rtqpcr
although
assay
sensit
matrixassoci
inhibitor
poorli
character
purpos
studi
develop
real
time
rtrpa
assay
rapid
detect
recent
epidem
human
noroviru
strain
evalu
perform
purifi
minim
process
outbreakderiv
clinic
stool
specimen
develop
screen
rtrpa
primer
probe
set
fortyeight
combin
candid
primer
forward
revers
gener
screen
reactiv
purifi
new
orlean
rna
primer
set
identifi
capabl
amplifi
target
rna
probe
design
would
accommod
set
tabl
primer
set
test
time
fluoresc
threshold
probe
compar
fig
six
primer
set
produc
signal
probe
two
signal
significantli
p
faster
three
set
also
perform
similarli
use
heat
stool
data
shown
one
set
discard
produc
signal
wide
inconsist
time
result
due
resourc
constraint
one
set
chosen
subsequ
evalu
evalu
rtrpa
perform
new
orlean
outbreak
sampl
rtrpa
perform
test
use
serial
dilut
stool
sampl
obtain
differ
individu
differ
gii
new
orlean
outbreak
occur
two
sampl
prepar
method
analyz
samplesconvent
rna
purif
direct
detect
boil
patient
stool
tabl
rtrpa
appli
seriallydilut
purifi
rna
sampl
produc
signal
wide
rang
viru
input
level
highli
repeat
identifi
viru
patient
sampl
rna
copi
number
rang
log
genom
copi
lgc
lgc
per
reaction
produc
posit
signal
fluoresc
within
min
min
overal
purifi
rna
input
lgc
rna
determin
rtqpcr
invers
proport
time
signal
rtrpa
analyz
linear
regress
figur
appli
heat
stool
rtrpa
perform
well
posit
signal
still
repeatedli
produc
outbreakderiv
stool
sampl
except
one
sampl
estim
input
genom
concentr
rang
lgc
posit
signal
produc
min
boil
stool
sampl
rtrpa
produc
posit
signal
sampl
high
level
inhibitor
exampl
rel
dirti
sampl
fecal
suspens
rtrpa
produc
posit
replic
rtqpcr
versu
posit
replic
stool
versu
stool
respect
figur
supplement
reaction
dimethyl
sulfoxid
dmso
formamid
rnase
inhibitor
improv
result
rtrpa
assay
figur
test
analyt
sensit
detect
limit
rtrpa
assay
serial
dilut
purifi
new
orlean
rna
three
patient
isol
test
replic
probit
regress
use
interpol
limit
detect
fig
rang
input
rna
produc
consist
posit
result
three
replic
lgc
time
threshold
floresc
min
min
respect
base
probit
regress
averag
limit
detect
assay
level
input
rna
sampl
would
posit
lgc
lgc
higher
limit
detect
determin
rtqpcr
predict
probit
lgc
specif
rtrpa
determin
use
panel
genom
extract
relev
enter
viru
bacteri
cultur
tabl
consist
posit
signal
observ
human
noroviru
strain
human
noroviru
produc
posit
signal
one
replic
one
dilut
otherwis
neg
sydney
strain
recent
circul
epidem
strain
repeatedli
produc
posit
signal
min
lgc
rang
input
rna
repeat
amplif
posit
signal
sydney
suggest
degre
base
mismatch
toler
rtrpa
system
despit
relianc
recombinas
enzym
tabl
total
mismatch
assay
target
region
compar
new
orlean
sydney
strain
wherea
mismatch
compar
new
orlean
sydney
differ
new
orlean
probe
region
base
mismatch
forward
revers
primer
target
region
respect
probe
forward
revers
primer
target
region
mismatch
like
revers
primer
target
region
reason
lack
consist
reactiv
work
rtrpa
assay
rapid
detect
human
noroviru
develop
proofofconcept
data
provid
use
detect
viru
repres
clinic
sampl
purifi
rna
extract
assay
limit
detect
lgc
per
reaction
human
fecal
sampl
posit
noroviru
new
orlean
extract
rna
isol
follow
rtrpa
viru
could
detect
patient
specimen
longer
amplif
time
target
signal
correspond
lower
input
templat
concentr
possibl
detect
noroviru
fecal
specimen
heat
releas
viral
rna
without
purif
heat
releas
method
lower
limit
detect
around
lgc
per
reaction
although
sensit
rtqpcr
rtrpa
assay
appear
similar
analyt
sensit
convent
rtpcr
human
noroviru
isotherm
assay
pointofcar
diagnost
particular
isotherm
amplif
method
great
interest
due
conveni
rapid
timetoresult
potenti
miniatur
two
method
well
studi
human
noroviru
detect
nucleic
acid
sequenc
base
amplif
nasba
loopmedi
isotherm
amplif
lamp
green
et
al
develop
first
noroviru
nasba
target
norwalk
viru
report
detect
limit
pcramplifi
unitsml
sampl
total
timetoresult
h
moor
et
al
evalu
sensit
specif
nasba
use
gi
gii
outbreak
strain
method
c
tabl
rtrpa
perform
purifi
rna
heat
stool
sampl
twelv
outbreak
stool
specimen
previous
confirm
posit
new
orlean
dilut
pb
either
subject
genom
rna
purif
serial
dilut
serial
dilut
boil
input
rang
test
sampl
b
lowest
input
level
signal
obtain
along
proport
replic
signal
obtain
input
level
c
standard
deviat
observ
due
one
posit
replic
abl
detect
strain
test
compar
rtpcr
gold
standard
sensit
specif
respect
differ
nasba
assay
design
target
junction
use
primer
reportedli
higher
analyt
sensit
approxim
concord
assay
reduc
timetoresult
min
first
human
noroviru
lamp
assay
target
similar
genom
region
rtrpa
design
detect
gi
gii
virus
detect
limit
l
reaction
sensit
specif
approach
result
achiev
min
yoda
et
al
design
lamp
assay
target
junction
abl
improv
detect
limit
l
reaction
increas
inclus
design
chang
anoth
studi
iturrizagomara
et
al
evalu
commerci
rtlamp
noroviru
detect
rel
rtpcr
find
slightli
lower
sensit
gi
rtlamp
higher
sensit
rtlamp
assay
newer
lamp
design
facilit
colorimetr
endpoint
use
even
genotyp
although
sever
isotherm
techniqu
amplif
detect
purifi
nucleic
acid
exist
rpa
multipl
advantag
ie
use
singl
tube
ii
realtim
detect
amplifi
product
use
fluoresc
probe
iii
inclus
requir
reagent
form
freezedri
pellet
simplifi
test
iv
inclus
bind
protein
report
aid
amplif
rna
target
tabl
exclus
specif
analysi
genom
rnadna
sever
enter
virus
bacteria
extract
use
nuclisen
easymag
biomerieux
dilut
extract
load
templat
rtrpa
assay
use
primerprob
set
c
show
low
reactiv
one
replic
sourc
organ
type
use
organ
may
present
human
enter
sampl
b
whether
amplifi
signal
observ
point
dilut
rtrpa
ye
proport
replic
posit
signal
obtain
present
parenthes
scientif
report
doi
high
degre
secondari
structur
v
reduc
time
posit
signal
disadvantag
respect
human
noroviru
detect
may
lack
broad
reactiv
ie
high
specif
perhap
recombinas
enzym
use
thought
higher
fidel
pcr
howev
work
degre
base
mismatch
appear
toler
abl
detect
two
differ
strain
although
older
strain
evalu
howev
method
reliabl
detect
noroviru
relev
genotyp
respons
least
noroviru
case
unit
state
outbreak
global
new
rtrpa
assay
could
redesign
rel
quickli
cover
new
epidem
strain
emerg
except
earli
work
green
et
al
first
studi
isotherm
amplif
fecal
suspens
without
prior
rna
extract
use
templat
result
gener
consist
green
et
al
rtrpa
assay
produc
posit
sampl
higher
concentr
fecal
materi
compar
rtqpcr
specif
studi
comparison
sampl
posit
stool
suspens
posit
rtrpa
less
sampl
posit
rtqpcr
figur
suggest
rtrpa
method
may
toler
inhibitori
compound
rpa
use
direct
detect
chlamydia
trachomati
urin
sampl
notabl
amplif
inhibit
occur
although
common
use
pcr
author
hypothes
rpa
would
less
suscept
amplif
inhibit
assay
reli
enzym
compon
condit
compar
biolog
system
exampl
use
recombinas
enzym
may
provid
increas
primer
bind
effici
polymeras
deriv
bacteri
speci
bacillu
subtili
grow
may
physiolog
familiar
would
amplif
reaction
occur
isotherm
condit
interestingli
isotherm
lamp
assay
also
shown
higher
toler
inhibitor
biolog
sampl
instanc
enotomoto
et
al
success
directli
detect
herp
simplex
swab
sampl
patient
gingiovostomat
vesicular
skin
erupt
year
kaneko
et
al
found
similar
evid
lamp
assay
consider
outperform
pcr
sampl
directli
amplifi
without
dna
purif
patient
genit
kerat
uveiti
perhap
comprehens
evalu
sampl
matrix
isotherm
amplif
kaneko
et
al
evalu
lamp
assay
rel
pcr
salin
solut
pb
modifi
eagl
medium
serum
plasma
urin
aqueou
vitreou
solut
differ
concentr
spike
low
level
dna
although
inhibit
inevit
note
high
concentr
assay
lamp
outperform
pcr
howev
comparison
isotherm
method
pcr
necessari
broad
conclus
impact
inhibitor
amplif
effici
made
noroviru
rtrpa
assay
display
poorer
analyt
sensit
detect
limit
sever
previous
report
assay
viral
pathogen
earlier
studi
use
rna
standard
determin
analyt
sensit
show
rtrpa
detect
limit
lgc
bovin
coronaviru
rift
valley
fever
ebola
marburg
sudan
sigma
virus
lgc
better
limit
detect
report
assay
howev
limit
detect
similar
report
foot
mouth
diseas
viru
assay
lgc
number
explan
differ
detect
limit
report
literatur
firstli
earlier
studi
detect
limit
base
rna
standard
gener
plasmid
studi
use
rna
directli
purifi
clinic
sampl
believ
latter
approach
produc
higher
detect
limit
biolog
relev
full
length
genom
may
consum
rpa
enzym
also
contain
region
increas
secondari
structur
imped
enzymat
action
altern
length
amplicon
report
longer
report
euler
et
al
amer
et
al
similar
length
report
abd
el
wahe
et
al
show
similar
higher
limit
detect
rtrpa
assay
abl
amplifi
two
recent
circul
epidem
noroviru
strain
impli
despit
high
fidel
assay
abl
toler
slight
differ
target
sequenc
agreement
boyl
et
al
report
two
differ
rpa
primerprob
set
capabl
amplifi
nearli
subtyp
includ
one
isol
mismatch
report
sydney
contain
total
mismatch
target
region
readili
amplifi
data
daher
et
al
focus
use
rpa
amplif
conserv
gene
sever
bacteria
show
similar
toler
base
pair
mismatch
interestingli
templat
inconsist
amplifi
primerprob
set
amplifi
region
contain
base
mismatch
end
target
region
addit
larg
number
mismatch
tabl
placement
mismatch
found
daher
et
al
inhibitori
amplif
intern
mismatch
fact
primerprob
set
report
amplifi
relev
enter
viru
bacteri
nucleic
acid
suggest
show
good
specif
reduc
likelihood
fals
posit
howev
futur
studi
build
upon
foundat
work
present
analyz
larger
number
divers
human
noroviru
clinic
sampl
must
complet
valid
evalu
suitabl
assay
larg
scale
clinic
set
instanc
analysi
tabl
sequenc
align
strain
sequenc
new
orlean
sydney
strain
well
strain
align
use
mega
softwar
packag
bold
sequenc
correspond
target
sequenc
region
base
mismatch
sydney
color
red
probe
target
region
exclud
mismatch
new
orlean
compar
sydney
respect
assay
reactiv
earlier
strain
genotyp
reactiv
genotyp
emerg
genotyp
signific
would
valuabl
futur
work
anoth
logic
futur
direct
build
work
would
design
optim
degener
primerprob
set
potenti
multiplex
assay
immedi
genogroup
analysi
first
report
use
emerg
rpa
technolog
rapid
detect
human
noroviru
rtrpa
multipl
advantag
rtqpcr
includ
lack
relianc
larger
expens
equip
amplif
detect
ii
use
recombinas
enzym
reduc
likelihood
fals
posit
result
due
inher
proofread
capabl
iii
quicker
timetoresult
iv
potenti
reduc
impact
matrixassoci
inhibitor
theoret
rtrpa
assay
capabl
direct
portabl
detect
epidem
human
noroviru
clinic
sampl
minim
expertis
less
minut
optim
particular
improv
analyt
sensit
comprehens
evalu
assay
specif
rtrpa
potenti
promis
altern
rtqpcr
isotherm
method
rapid
test
human
noroviru
gener
human
noroviru
rna
standard
rtqpcr
amplifi
genom
copi
sampl
determin
use
rna
standard
curv
previous
describ
briefli
extract
new
orlean
rna
access
number
first
amplifi
primer
tabl
use
superscript
onestep
rtpcr
kit
invitrogen
carlsbad
ca
l
templat
min
revers
transcript
cycl
follow
enzym
inactiv
min
amplif
perform
cycl
sec
sec
sec
nucleotid
amplicon
gel
purifi
use
qiaquick
gel
extract
kit
qiagen
hilden
germani
subject
vitro
transcript
use
megashortscript
kit
thermo
fisher
waltham
accord
manufactur
instruct
transcrib
rna
purifi
quantifi
nanophotomet
pearl
denvil
scientif
south
plainfield
nj
serial
dilut
use
construct
standard
curv
rtqpcr
use
primer
probe
set
tabl
superscript
onestep
rtpcr
kit
cycl
anneal
temperatur
rna
standard
curv
use
estim
rna
copi
number
extract
patient
stool
sampl
cq
evalu
threshold
flouresc
unit
use
biorad
cfx
manag
softwar
reaction
perform
triplic
real
time
rtrpa
primer
probe
design
primer
rtrpa
design
follow
manufactur
guidelin
twistdx
inc
cambridg
uk
target
primer
design
rel
conserv
junction
previous
report
conserv
region
noroviru
capsid
near
ns
domain
initi
screen
one
optim
perform
primer
set
select
correspond
probe
design
accord
manufactur
instruct
twistdx
inc
tabl
primer
provid
integr
dna
technolog
idt
coralvil
ia
probe
provid
biosearch
technolog
novato
ca
rtrpa
reaction
condit
rtrpa
reaction
carri
use
twistamp
exo
rt
kit
twistdx
inc
l
reaction
contain
pmol
forward
revers
primer
pmol
probe
l
proprietari
rehydr
buffer
l
templat
nucleasefre
water
l
reaction
mixtur
ad
rehydr
twistamp
exo
rt
lyophil
enzym
pellet
l
mm
magnesium
acet
ad
top
reaction
tube
lid
magnesium
acet
droplet
spun
use
minifug
timer
immedi
start
reaction
quickli
transfer
biorad
cfx
thermal
cycler
biorad
hercul
ca
set
cycl
read
everi
sec
five
min
reaction
start
cycler
paus
reaction
mix
spun
place
back
thermal
cycler
continu
cycl
total
time
produc
signal
calcul
follow
equat
evalu
purifi
rna
heat
stool
sampl
use
rtrpa
rtqpcr
twenti
percent
suspens
noroviru
new
orleansconfirm
clinic
sampl
patient
serial
dilut
rna
releas
heat
biorad
thermal
cycler
biorad
hercul
ca
min
tube
cool
ice
mix
briefli
centrifug
heat
stool
dilut
use
directli
templat
rtrpa
reaction
describ
rtqpcr
reaction
use
scientif
report
doi
primer
probe
set
tabl
addit
nuclisen
easymag
rna
extract
clinic
sampl
serial
dilut
use
rtrpa
rtqpcr
degre
correl
rtrpa
time
detect
min
log
genom
copi
input
standard
curv
determin
linear
regress
use
microsoft
excel
figur
evalu
rtrpa
assay
analyt
sensit
serial
dilut
purifi
rna
three
select
stool
sampl
sampl
test
use
describ
total
replic
probit
regress
perform
use
jmp
softwar
packag
sa
cari
nc
limit
detect
standard
deviat
calcul
averag
three
valu
produc
regress
valu
reflect
predict
lgc
test
would
produc
posit
result
reaction
set
includ
templat
control
confirm
lack
contamin
exclus
test
sequenc
analysi
specif
evalu
analyz
multipl
relev
enter
viru
bacteri
strain
cross
reactiv
rtrpa
assay
tabl
purifi
genom
nucleic
acid
serial
dilut
dilut
use
directli
templat
rtrpa
analyz
degre
sequenc
differ
new
orlean
primer
design
two
human
noroviru
strain
sydney
sequenc
align
perform
clustal
w
analysi
use
mega
softwar
suit
